{"title":"Lifestyle Changes For People With Non Communicable Diseases In The COVID-19 era: A Survey Conducted Around The World","authors":"L. H., B. R.","doi":"10.47690/jcv.2021.1404","DOIUrl":"https://doi.org/10.47690/jcv.2021.1404","url":null,"abstract":"","PeriodicalId":285711,"journal":{"name":"JOURNAL OF CORONA VIRUS COVID19","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125361547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G. H, M. D., Adamovic I, Blob H-B, D. S, Kühnlein P, Mäffert R, Raabe A, Sterner M-G, Zintl K, Zühlke C, Đogaš Z
{"title":"Vaccination Attitudes and Impact of the Second COVID-19 Lockdown on Mood, Mental State, and Exercise Habits in Germany: A Cross-Sectional Study","authors":"G. H, M. D., Adamovic I, Blob H-B, D. S, Kühnlein P, Mäffert R, Raabe A, Sterner M-G, Zintl K, Zühlke C, Đogaš Z","doi":"10.47690/jcv.2021.1402","DOIUrl":"https://doi.org/10.47690/jcv.2021.1402","url":null,"abstract":"","PeriodicalId":285711,"journal":{"name":"JOURNAL OF CORONA VIRUS COVID19","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128509186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Striking Biochemical Markers in Laboratory Diagnosis for People in COVID-19 Pandemic","authors":"I. K, Muge Mk, Erdi At","doi":"10.47690/jcv.2021.1405","DOIUrl":"https://doi.org/10.47690/jcv.2021.1405","url":null,"abstract":"","PeriodicalId":285711,"journal":{"name":"JOURNAL OF CORONA VIRUS COVID19","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125002219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Laser Therapy in the Complex Prevention and Treatment of COVID-19 (Preliminary Results)","authors":"Mikhaylov Va","doi":"10.47690/jcv.2021.1103","DOIUrl":"https://doi.org/10.47690/jcv.2021.1103","url":null,"abstract":"","PeriodicalId":285711,"journal":{"name":"JOURNAL OF CORONA VIRUS COVID19","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122352241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tahereh Sabaghian, Almasi Mh, M. Raoufi, H. Ebrat, Alavi Aa, O. Moradi, F. Masbough, A. Falsafi, S. Yaghmaei
Prognostic Factors in Patients with AKI and COVID-19. ABSTRACT Background : Acute kidney injury is challenging in the context of the COVID-19 pandemic. Up to 30 % of critically ill COVID-19 pa tients develop AKI. Thus, it is imperative to determine what factors may predict the likelihood of these patients developing more severe and potentially life-threatening conditions. Objective : The aim of this study is to investigate the clinical and computed tomography features associated with poor prognostic factors in COVID-19 patients developing AKI. We also aimed to investigate chest CT score and its pattern in AKI patients in the COVID-19 setting. Materials and Methods : 415 patients with COVID-19 pneumonia were enrolled. 64 patients have been excluded due to a history of chronic kidney disorders. Finally, 351 patients, including 100 AKI cases and 251 non-AKI cases, were enrolled. The chest CT images and clinical data of them were reviewed and compared. The CT scores and the risk factors associated with disease severity were discussed. Results: Compared with the non-AKI group, the AKI patients had older ages and a higher incidence of certain comorbidities, such as hypertension and cardiovascular disorders. In AKI patients, the value of inflammatory markers, e.g., CRP, LDH, PCT, and Lactate level were significantly higher than those of the ordinary patients (P<0.05). In addition, the AKI patients showed higher incidences of lymphopenia (P=0.019) and leukocytosis (P=0.023). In the AKI group, the CT-scores were significantly higher than those of the non-AKI group (P < 0.001), and severe CT- scores were mainly associated with AKI. ROC analysis showed that 71.4 % sensitiv ity and 90 % specificity for CT scores higher than 13 in the AKI group. Out of all measured parameters, CT-score and the level of PCT, lactate, and WBC were the most reliable factors for predicting mortality in AKI patients. Conclusions: There are significant differences in clinical symp -toms, laboratory examinations, and CT manifestations between the AKI and non-AKI patients in the COVID-19 setting. Many factors are associated with the severity of the illness, which can help clinicians assess patients' prognosis.
{"title":"Prognostic Factors in Patients with AKI and COVID-19","authors":"Tahereh Sabaghian, Almasi Mh, M. Raoufi, H. Ebrat, Alavi Aa, O. Moradi, F. Masbough, A. Falsafi, S. Yaghmaei","doi":"10.47690/jcv.2021.1301","DOIUrl":"https://doi.org/10.47690/jcv.2021.1301","url":null,"abstract":"Prognostic Factors in Patients with AKI and COVID-19. ABSTRACT Background : Acute kidney injury is challenging in the context of the COVID-19 pandemic. Up to 30 % of critically ill COVID-19 pa tients develop AKI. Thus, it is imperative to determine what factors may predict the likelihood of these patients developing more severe and potentially life-threatening conditions. Objective : The aim of this study is to investigate the clinical and computed tomography features associated with poor prognostic factors in COVID-19 patients developing AKI. We also aimed to investigate chest CT score and its pattern in AKI patients in the COVID-19 setting. Materials and Methods : 415 patients with COVID-19 pneumonia were enrolled. 64 patients have been excluded due to a history of chronic kidney disorders. Finally, 351 patients, including 100 AKI cases and 251 non-AKI cases, were enrolled. The chest CT images and clinical data of them were reviewed and compared. The CT scores and the risk factors associated with disease severity were discussed. Results: Compared with the non-AKI group, the AKI patients had older ages and a higher incidence of certain comorbidities, such as hypertension and cardiovascular disorders. In AKI patients, the value of inflammatory markers, e.g., CRP, LDH, PCT, and Lactate level were significantly higher than those of the ordinary patients (P<0.05). In addition, the AKI patients showed higher incidences of lymphopenia (P=0.019) and leukocytosis (P=0.023). In the AKI group, the CT-scores were significantly higher than those of the non-AKI group (P < 0.001), and severe CT- scores were mainly associated with AKI. ROC analysis showed that 71.4 % sensitiv ity and 90 % specificity for CT scores higher than 13 in the AKI group. Out of all measured parameters, CT-score and the level of PCT, lactate, and WBC were the most reliable factors for predicting mortality in AKI patients. Conclusions: There are significant differences in clinical symp -toms, laboratory examinations, and CT manifestations between the AKI and non-AKI patients in the COVID-19 setting. Many factors are associated with the severity of the illness, which can help clinicians assess patients' prognosis.","PeriodicalId":285711,"journal":{"name":"JOURNAL OF CORONA VIRUS COVID19","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130322262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Immunity and Spiritual Care in Prevention of Covid 19","authors":"Karati D","doi":"10.47690/jcv.2021.1401","DOIUrl":"https://doi.org/10.47690/jcv.2021.1401","url":null,"abstract":"","PeriodicalId":285711,"journal":{"name":"JOURNAL OF CORONA VIRUS COVID19","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126524607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Diagnosis and Management of TCM On Infected Or Suspected Patients with Covid-19 ------48 Cases Study in UK","authors":"J. D","doi":"10.47690/jcv.2021.1403","DOIUrl":"https://doi.org/10.47690/jcv.2021.1403","url":null,"abstract":"","PeriodicalId":285711,"journal":{"name":"JOURNAL OF CORONA VIRUS COVID19","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131608398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Al odda Bka, Mohammed Zb, Muhealddina Dl, Abdullah Km, Qadir Ao, Shrif Ra, Fakrealdeen Ga, Al odda Zbk, Al odda Gbk
BACKGROUND: A recent human’s pandemic of respiratory disease caused by a novel (new) coronavirus that rapidly spreads in the community and may causing life threating complications. All those exposed to it is at risk of becoming infected and getting COVID-19. Cancer Patients may be more likely at risk to getting the infection and developing life threating morbidity and even death as those cancer patients may have weakened immunity either because of the cancer treatment or direct effect of the disease. OBJECTIVE: To obtain local data on the pattern of children and adolescent with cancer on treatment who have been infected with SARS-CoV-2 in our community and compare it with that of noncancerous patients. Journal Home: https://www.scienceworldpublishing.org/journals/journal-of-corona-virus-/COVID19 2/7 Journal of Corona Virus Volume: 1.1 PATIENTS AND METHODS: A prospective study conducted on 54 pediatric patients with cancer during their treatment with chemotherapy that developed RT-PCR approved COVID-19 in Sulaymaniyah Governorate-Kurdistan region of Iraq from April 2020 to October 2020 were carried out to analyze the demographic features and their clinical manifestation. Data analyzed using SPSS software; version 13 and P-value obtained by Chi-square test. RESULTS: The median age at diagnosis was about 7 and peak age incidence occurred in adolescent between 13-17 years old with slightly female predominance. There was no correlation between gender and severity; patients with hematological malignancies seem to have more severe COVID-19 manifestation than solid tumor. CONCLUSION: Overall morbidity and mortality from COVID-19 in cancer patients is seem to be similar to noncancerous patients. INTRODUCTION Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes coronavirus disease 2019 (COVID-19), the respiratory illness responsible for the COVID-19 pandemic [1, 2]. SARS-CoV-2 is a member of the family Coronaviridae and orders Nidovirales, is an enveloped and positive-sense single-stranded RNA (+ssRNA) virus[3]. The incidence of SARS-CoV-2 infection is seen most often in adult male patients with the median age of the patients was between 34 and 59 years [4,5], SARS-CoV-2 is also more likely to infect people with chronic comorbidities such as cardiovascular and cerebrovascular diseases and diabetes [6]. The highest proportion of severe cases occurs in adult’s ≥60 years of age, and in those with certain underlying conditions, such as cardiovascular and cerebrovascular diseases and diabetes [4, 5]. Severe manifestations maybe also associated with coinfections of bacteria and fungi [6]. Fewer COVID-19 cases have been reported in children less than 15 years [5, 7, 8]. In a study of 425 COVID-19 patients in Wuhan, published on January 29, there were no cases in children under 15 years of age [9], Nevertheless, 28 pediatric patients have been reported by January 2020. The clinical features of infected pediatric patients vary, but
{"title":"Characteristics of COVID-19 in Pediatric Patients with Malignancy in Sulaymaniyah Governorate, Kurdistan Region of Iraq","authors":"Al odda Bka, Mohammed Zb, Muhealddina Dl, Abdullah Km, Qadir Ao, Shrif Ra, Fakrealdeen Ga, Al odda Zbk, Al odda Gbk","doi":"10.47690/JCV.2021.1104","DOIUrl":"https://doi.org/10.47690/JCV.2021.1104","url":null,"abstract":"BACKGROUND: A recent human’s pandemic of respiratory disease caused by a novel (new) coronavirus that rapidly spreads in the community and may causing life threating complications. All those exposed to it is at risk of becoming infected and getting COVID-19. Cancer Patients may be more likely at risk to getting the infection and developing life threating morbidity and even death as those cancer patients may have weakened immunity either because of the cancer treatment or direct effect of the disease. OBJECTIVE: To obtain local data on the pattern of children and adolescent with cancer on treatment who have been infected with SARS-CoV-2 in our community and compare it with that of noncancerous patients. Journal Home: https://www.scienceworldpublishing.org/journals/journal-of-corona-virus-/COVID19 2/7 Journal of Corona Virus Volume: 1.1 PATIENTS AND METHODS: A prospective study conducted on 54 pediatric patients with cancer during their treatment with chemotherapy that developed RT-PCR approved COVID-19 in Sulaymaniyah Governorate-Kurdistan region of Iraq from April 2020 to October 2020 were carried out to analyze the demographic features and their clinical manifestation. Data analyzed using SPSS software; version 13 and P-value obtained by Chi-square test. RESULTS: The median age at diagnosis was about 7 and peak age incidence occurred in adolescent between 13-17 years old with slightly female predominance. There was no correlation between gender and severity; patients with hematological malignancies seem to have more severe COVID-19 manifestation than solid tumor. CONCLUSION: Overall morbidity and mortality from COVID-19 in cancer patients is seem to be similar to noncancerous patients. INTRODUCTION Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes coronavirus disease 2019 (COVID-19), the respiratory illness responsible for the COVID-19 pandemic [1, 2]. SARS-CoV-2 is a member of the family Coronaviridae and orders Nidovirales, is an enveloped and positive-sense single-stranded RNA (+ssRNA) virus[3]. The incidence of SARS-CoV-2 infection is seen most often in adult male patients with the median age of the patients was between 34 and 59 years [4,5], SARS-CoV-2 is also more likely to infect people with chronic comorbidities such as cardiovascular and cerebrovascular diseases and diabetes [6]. The highest proportion of severe cases occurs in adult’s ≥60 years of age, and in those with certain underlying conditions, such as cardiovascular and cerebrovascular diseases and diabetes [4, 5]. Severe manifestations maybe also associated with coinfections of bacteria and fungi [6]. Fewer COVID-19 cases have been reported in children less than 15 years [5, 7, 8]. In a study of 425 COVID-19 patients in Wuhan, published on January 29, there were no cases in children under 15 years of age [9], Nevertheless, 28 pediatric patients have been reported by January 2020. The clinical features of infected pediatric patients vary, but ","PeriodicalId":285711,"journal":{"name":"JOURNAL OF CORONA VIRUS COVID19","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117188203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Majeed Sa, Haneefa S, Reghukumar A, M. S, Kiron Js
{"title":"Design Strategies To Improve Healthcare Worker Safety In Doffing Units: An Evidence Based Study In Bio secure Mobile Doffing Unit","authors":"Majeed Sa, Haneefa S, Reghukumar A, M. S, Kiron Js","doi":"10.47690/jcv.2021.1302","DOIUrl":"https://doi.org/10.47690/jcv.2021.1302","url":null,"abstract":"","PeriodicalId":285711,"journal":{"name":"JOURNAL OF CORONA VIRUS COVID19","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115619167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：